Sichuan, China

Wen Yu

This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Huitai Biomedicine Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Yu. Retrieved from https://idiyas.com/inventor/wen-yu-reixvre3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Wen Yu

Introduction

Wen Yu is a notable inventor based in Sichuan, China. He has made significant contributions to the field of biomedicine, particularly in the development of polypeptides. His work focuses on creating solutions for serious health issues, including fibrosis diseases.

Latest Patents

Wen Yu holds a patent for a polypeptide, polypeptide fragment, and derivatives thereof. This invention includes applications for the preparation of drugs aimed at preventing and treating fibrosis diseases. His innovative approach has the potential to impact the medical field significantly.

Career Highlights

Wen Yu is currently employed at Chengdu Huitai Biomedicine Co., Ltd. His role at the company allows him to further his research and development efforts in biomedicine. With a focus on practical applications, he aims to translate his inventions into real-world solutions.

Collaborations

Wen Yu collaborates with talented individuals in his field, including Xiaohong Chen and De Wei. These partnerships enhance his research capabilities and foster innovation within the company.

Conclusion

Wen Yu's contributions to the field of biomedicine through his patent and work at Chengdu Huitai Biomedicine Co., Ltd. highlight his commitment to advancing medical science. His innovative spirit and collaborative efforts are paving the way for future breakthroughs in treating fibrosis diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…